期刊文献+

上焦宣痹汤对小儿支原体肺炎痰热闭肺证临床观察 被引量:4

Clinical observation of Shangjiao Xuanbi Decoction in treating Mycoplasmal Pneumonia with phlegm heat closed in the lung syndrom
原文传递
导出
摘要 目的观察上焦宣痹汤对小儿支原体肺炎痰热闭肺证的临床疗效。方法将确诊患儿随机分为治疗组和对照组,各55例。对照组口服阿奇霉素颗粒,并给予对症治疗。治疗组在对照组治疗基础上应用上焦宣痹汤加减治疗,7 d为1个疗程,1个疗程后统计疗效。结果治疗组治愈率为74.54%,总有效率为92.73%;对照组治愈率为54.55%,总有效率为85.45%,治疗组的治愈率和总有效率均高于对照组(P<0.05)。结论上焦宣痹汤可明显改善小儿痰热闭肺型肺炎的临床症状、肺部体征以及中医症候,提高小儿支原体肺炎治愈率,缩短其治疗时间,值得临床推广应用。 Objective To observe the curative effect of Shangjiao Xuanbi Decoction on infantile mycoplasmal pneumonia with the syndrome of phlegm heat closed in the lung. Methods Patients were randomized into treat- ment group and control group, 55 cases in each group. The control group was given oral Azithromycin Granules and symptomatic treatment. The treatment group was additionally applied Shangjiao Xuanbi decoction, 7 d a course. 1 course after, statistical analysis was made. Results In the treatment group, the curative rate was 74.54%, the total efficiency was 92.73% ; in the control group, the curative rate was 54.55%, the total effective rate was 85.45 %. The curative rate and total effective rate in the treatment group were higher than that in the control group ( P〈0.05 ). Conclusion Shangjiao Xuanbi Decoction can significantly improve clinical symptoms, signs and syn- drome of mycoplasma pneumonia with pediatric phlegm heat closed the lungs, heighten the curative rate of pneumo- nia, shorten the time of treatment, worthy of clinical application.
出处 《中医儿科杂志》 2014年第3期30-32,共3页 Journal of Pediatrics of Traditional Chinese Medicine
关键词 上焦宣痹汤 小儿支原体肺炎 痰热闭肺 疗效观察 Shangjiao Xuanbi Decoction mycoplasma pneumonia phlegm heat closed in the lung curativeeffect observation
  • 相关文献

参考文献6

二级参考文献36

  • 1丁樱,刘宏宣,高希章,高春义.小儿消积止咳口服液的临床研究[J].中国医药学报,1996,11(5):8-10. 被引量:12
  • 2Khair OA,Devalia JL,Abdelaziz MM,et al.Effects of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6,IL-8 and SICAM-1 by cultured human bronchial epithelial cells.Eur Respir J,1995,8:1451-1457.
  • 3Culic O,Erakovic V,Parnham MJ.Anti-inflammatory effects of macrolide antibiotics.Eur J Pharmacol,2001,429:209-229.26 Tsang KW,Ho PI,Chan KN,et al.A pilot study of low-dose erythromycin in bronchiectasis.Eur Respir J,1999,13:361-364.27 Wolter J,Seeney S,Be
  • 4Khair OA,Devalia JL,Abdelazia MM,et al.Effect of erythromycin on Haemophilus influenzae endotoxin-induced released of IL-6/IL-8 and Sicam-1 by cultured human bronchial epithelial cells.Europen Respir J,1995,8:1451-1457.
  • 5Sakito O,Kadota J,Kohno S,et al.Interleukin 1 beta,tumor necrosis factor alpha,and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy.Respiration,1996,63:42-48.
  • 6Schultz MJ,Speelman P,Hack CE,et al.Intravenous infusion of erythromycin inhibits CXC chemokine production,but aguement neutrophil degranulation in whole blood stimulated with streptococcus pneumonia.J Antimicrob Chemother,2000,46:235-240.
  • 7Sugihura E.Effects of macrolide aqntibiotics on neutrophils function in human peripheral blood.Kansenshogaku Zasshi,1997,71:329-336.
  • 8Ball BD,Hill MR,Brenner M,et al.Effects of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.Ann Allergy,1990,65:37-45.
  • 9Takizawa H,Desaki T,Ohtoshi T,et al.Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells.Eur Respir J,1998,12:57-63.
  • 10Theron AJ,Feldman C,Anderson R.Investigation of the anti-inflammatory and membrane-stabilizing potential of spiramycin in vitro.J Antimicrob Chemother,2000,46:269-271.

共引文献248

同被引文献57

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部